Massimo Di Maio/X
Jan 31, 2025, 16:44
The importance of QOL and PRO in clinical research by Massimo Di Maio
Giuseppe Procopio, Director of the Genitourinary cancer Unit at National Cancer Institute Foundation, shared on X:
“After the interesting presentation of Dr. Pruneri, Dr. Massimo Di Maio is presenting on ‘QOL and PRO as the Best Endpoints for Clinical Trials’, focusing on the importance of QOL and PRO in clinical research.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 26, 2025, 17:54
Jun 26, 2025, 17:47
Jun 26, 2025, 17:29
Jun 26, 2025, 14:50
Jun 26, 2025, 14:20